iCureASPS is Marking 20 Years of Activity

by Yosef
August 2, 2023

iCureASPS is Marking 20 Years of Activity

The first weekend of August 2023 is marking 20 years of iCureASPS efforts to find a […]
0
read more
by Yosef
December 17, 2022

FDA Grants Approval to Atezolizumab for Alveolar Soft Part Sarcoma

On December 9, 2022, the Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for […]
0
read more
by Yosef
July 4, 2022

Summer 2022: Updated Clinical Research on Alveolar Soft Part Sarcoma

Below are links to eighteen publications describing clinical studies of ASPS with novel treatments as well […]
0
read more
by Yosef
July 4, 2022

Please Support “Team ASPS” 2022 PMC Bike Ride at The PMC in Search for Cure

Dear Friends, On Saturday and Sunday August 6 and 7th, 2022, Team ASPS will ride for […]
0
read more
by Yosef
August 7, 2021

Please donate to support Team ASPS efforts to find a cure for Alveolar Soft Part Sarcoma: 2021 PMC bike ride

Update:  On August the 8th, 2021, Team ASPS Completed the PMC Bike Ride of 100 Miles, […]
0
read more
by Yosef
September 26, 2020

Phase 2 Clinical Trial for Alveolar Soft Part Sarcoma Patients: Testing Atezolizumab, A Study by the NCI

Dear ASPS community, please read the recent update of this clinical trial from September 2020: This […]
0
read more
by Yosef
June 30, 2019

2019 Progress Report on Alveolar Soft Part Sarcoma – American Society of Clinical Oncology (ASCO) annual meeting

We selected to highlight 3 studies that were presented this year at the ASCO conference: 1.   Treatment […]
0
read more
by Yosef
July 29, 2018

Progress Reports on Alveolar Soft Part Sarcoma from the ASCO 2018 Meeting

The American Society of Clinical Oncology (ASCO) annual meeting took place this year in Chicago between […]
0
read more
by Yosef
January 6, 2018

Update on Alveolar Soft Part Sarcoma Clinical and Preclinical Studies as Presented at the Annual Meeting of CTOS in November 8-11, 2017

Below are summaries of three clinical studies and one preclinical study on Alveolar Soft Part Sarcoma […]
0
read more
by Yosef
July 22, 2017

New ASPS Trial: A​​PROMISS – A Phase III Trial of Anlotinib for Patients with Alveolar Soft Part Sarcoma and Other Sarcomas

OPEN NOW: ​​​APROMISS – A Phase III Study of AL3818 (Anlotinib) Hydrochloride Monotherapy in Subjects With […]
0
read more